Israel vs Moldova: Cause of death, by non-communicable diseases, ages 15-59, male
Israel
60.0%
in 2021
Moldova
58.8%
in 2021
Israel rank
61st
Moldova rank
63rd
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Israel
- Moldova
How they compare
Israel currently reports 60.0% against 58.8% in Moldova, a difference of 1.2%.
Across all 6 years both countries report, Israel has been ahead every year.
Israel ranks 61st and Moldova ranks 63rd of 185 countries.
Israel has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Israel | Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 65.9% | 64.4% | 1.5% | Israel |
| 2010s | 71.9% | 67.4% | 4.4% | Israel |
| 2020s | 64.7% | 60.2% | 4.5% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Israel or Moldova?
- Israel, at 60.0% against 58.8% in Moldova as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Israel and Moldova?
- 1.2%, with Israel ahead.
- How many years of comparable data are there for Israel and Moldova?
- 6 years are reported by both, from 2000 to 2021.
- How do Israel and Moldova rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Israel ranks 61st and Moldova ranks 63rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.